Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report

BACKGROUND: Great progress has recently been made in the treatment of metastatic renal cell carcinoma, including the introduction of nivolumab, an immune checkpoint inhibitor. Despite promising results, this treatment brings a completely new spectrum of adverse events, distinct from those experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopecký, Jindřich, Kubeček, Ondřej, Geryk, Tomáš, Slováčková, Birgita, Hoffmann, Petr, Žiaran, Miroslav, Priester, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138913/
https://www.ncbi.nlm.nih.gov/pubmed/30217214
http://dx.doi.org/10.1186/s13256-018-1786-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138913/
https://www.ncbi.nlm.nih.gov/pubmed/30217214
http://dx.doi.org/10.1186/s13256-018-1786-9

Ejemplares similares